SEC 13F Intelligence

Sivik Global Healthcare LLC / LLY

Sivik Global Healthcare LLC’s Eli Lilly & Co Position

Does Sivik Global Healthcare LLC own Eli Lilly & Co (LLY)? Yes — 5.0K shares worth $5M (+3.49% of its 13F portfolio) as of Q1 2026, down from 7.0K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
5.0K
% of Portfolio
+3.49%
Quarters Held
28
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $9MQ2 ’19: $6MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $4MQ3 ’20: $8MQ4 ’20: $6MQ2 ’21: $9MQ2 ’21Q3 ’21: $8MQ4 ’21: $8MQ1 ’22: $3MQ2 ’22: $7MQ2 ’22Q3 ’22: $6MQ4 ’22: $6MQ1 ’23: $7MQ2 ’23: $8MQ2 ’23Q3 ’23: $8MQ4 ’23: $9MQ1 ’24: $12MQ2 ’24: $14MQ2 ’24Q3 ’24: $13MQ4 ’24: $12MQ1 ’25: $7MQ2 ’25: $9MQ2 ’25Q3 ’25: $8MQ4 ’25: $8MQ1 ’26: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.0K$5M+3.49%
Q4 20257.0K$8M+2.18%
Q3 202510.0K$8M+2.22%
Q2 202511.0K$9M+2.33%
Q1 20259.0K$7M+4.02%
Q4 202415.0K$12M+6.10%
Q3 202414.5K$13M+5.44%
Q2 202415.0K$14M+4.88%
Q1 202416.0K$12M+2.92%
Q4 202315.0K$9M+3.65%
Q3 202315.0K$8M+4.07%
Q2 202317.5K$8M+1.92%
Q1 202320.0K$7M+2.95%
Q4 202217.5K$6M+3.01%
Q3 202217.5K$6M+3.14%
Q2 202221.5K$7M+3.96%
Q1 202210.0K$3M+1.18%
Q4 202127.5K$8M+3.25%
Q3 202135.0K$8M+1.93%
Q2 202140.0K$9M+1.79%
Q4 202035.0K$6M+2.41%
Q3 202055.0K$8M+3.50%
Q1 202060.0K$4M+1.73%
Q4 201950.0K$7M+2.44%
Q3 201955.0K$6M+3.10%
Q2 201955.0K$6M+1.47%
Q1 201970.0K$9M+3.35%
Q4 201855.0K$6M+3.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of LLY.